Gene Therapy webinar series – Episode 1: Overview of gene therapy developments for clinicians & Gene therapy in clinical practice

2 April 2024


…TIMESLOT: Tuesday 2 April 2024 17:00 – 18:00 CET

…THEME:  Overview of gene therapy developments for clinicians & Gene therapy in clinical practice

…PRESENTERS: Dr. Francina Munell Casadesus (Hospital Universitari Vall D’Hebron, Barcelona, Spain) & Laurent Servais (University of Oxford, United Kingdom)

…BIOSKETCH: Dr. Francina Munell is a Pediatric Neurologist working at Vall d’Hebrón University Hospital, Barcelona (Spain), and the coordinator of the Pediatric Neuromuscular Unit. Her main interest is the study of the early onset neuromuscular disorders. She participates in clinical trials using gene therapy in SMA and Duchenne Muscular Dystrophy, in research projects aiming to develop a therapeutic strategy for LAMA2-MD and in the elaboration of a guideline for gene therapy in neuromuscular disorders in Spain.  

 

Professor Servais’ main research interests cover innovative outcome measures and clinical trials design and newborn screening (NBS). He has been involved as Principal Investigator in several clinical trials in spinal muscular atrophy (SMA), Angelman Syndrome X-linked myotubular myopathy, and Duchenne muscular dystrophy (DMD), and in leading the NBS program for SMA NBS in Belgium and in the UK. He is the coordinating investigator of two large natural history studies in Angelman in the UK and in Belgium that aims to identify and validates innovative outcome measures and biomarkers. 

Fore more information on the full Gene Therapy webinar series click here!

 

Further details

The ERNs are co-funded by the
European Union (Health Programme and CEF)

EU Commission


“EURO-NMD is one of the 24 European Reference Networks (ERNs) approved by the ERN Board of Member States. The ERNs are co-funded by the European Union (Health Programme and CEF).
For more information about the ERNs and the EU health strategy,
please visit ec.europa.eu/health/ern